Profile for South Korea Patent: 20150041794
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for South Korea Patent: 20150041794
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Jul 26, 2032 | Braeburn | BRIXADI | buprenorphine |
| ⤷ Start Trial | Jul 26, 2032 | Braeburn | BRIXADI | buprenorphine |
| ⤷ Start Trial | Jul 26, 2032 | Braeburn | BRIXADI | buprenorphine |
| ⤷ Start Trial | Jul 26, 2032 | Braeburn | BRIXADI | buprenorphine |
| ⤷ Start Trial | Jul 26, 2032 | Braeburn | BRIXADI | buprenorphine |
| ⤷ Start Trial | Jan 10, 2027 | Braeburn | BRIXADI | buprenorphine |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
